Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Long-Term-Debt" stands at 50.00 Billion Japanese Yens as of 06/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 102.60 percent compared to the value the year prior.
The 1 year change in percent is 102.60.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Debt | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Debt | 280,205,508,085.11 |